Medical Analysis Systems
This article was originally published in The Gray Sheet
Executive SummaryClinical diagnostics manufacturer agrees to purchase the assets of Dade Behring's line of lyophilized (freeze-dried) controls under an agreement in principle announced June 9. Under terms of the deal, which is expected to be complete in four to six weeks, MAS gains a quality control data management system, intellectual property rights to the products, manufacturing equipment, Dade's existing customer base and 26-27 of the firm's employees. The purchase will expand existing liquid stabilization products for controls, calibrators and reagents. Terms of the deal were not disclosed
You may also be interested in...
US investigators fan out to non-China inspection priorities and Secretary Azar talks supply management; warning letters hit record keeping, investigations and basic GMP compliance.
Mallinckrodt to pay $1.6bn and place its generics unit in bankruptcy under agreement in principle for US global settlement; six states are not on board, including New York, whose suit is still set to go to trial March 20.
The company has reached a broad opioid settlement agreement in principle under which its specialty generics subsidiaries would file for Chapter 11 bankruptcy and Mallinckrodt's branded business would operate separately.